Valuation: Universal Vision Biotechnology Co., Ltd.

Market Cap 11.48B 356M 311M 288M 265M 500M 34.3B 509M 3.44B 1.35B 16.77B 1.34B 1.31B 57.79B P/E 2026 *
10.1x
P/E 2027 * -
Enterprise Value 11.48B 356M 311M 288M 265M 500M 34.3B 509M 3.44B 1.35B 16.77B 1.34B 1.31B 57.79B EV / Sales 2026 *
2.7x
EV / Sales 2027 * 2.59x
Free-Float
47.64%
Yield 2026 *
5.93%
Yield 2027 * -
05-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-04 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
11-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
24-11-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-09 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024 CI
1 day+1.12%
1 week-3.90%
Current month-1.09%
1 month+1.50%
3 months+2.65%
6 months-9.67%
Current year-7.19%
1 week 132.5
Extreme 132.5
141
1 month 130.5
Extreme 130.5
148
Current year 122
Extreme 122
154
1 year 122
Extreme 122
219.5
3 years 122
Extreme 122
381.13
5 years 122
Extreme 122
432.08
10 years 18.64
Extreme 18.6433
432.08
Manager TitleAgeSince
Chief Executive Officer - 2010-01-31
Director of Finance/CFO - 2016-03-31
President - -
Director TitleAgeSince
Director/Board Member - 2003-06-01
Chairman - 2012-06-27
Director/Board Member 66 2012-06-27
Change 5-day change 1-year change 3-year change Capi.($)
+1.12%-3.90%-32.42%-63.82% 350M
+0.93%-1.84%-30.99%-3.79% 87.69B
+0.11%+4.26%-19.08%-21.71% 34.29B
-0.17%+1.26%-1.43%-27.47% 13.99B
+0.84%-0.36% - - 9.7B
-6.59%-10.76%-35.18%+441.22% 1.88B
+1.54%+4.39%-29.95%-64.09% 1.45B
-0.48%+0.98%-37.13%-26.99% 858M
+0.15%-10.53%+11.46%-8.71% 794M
-2.26%+1.38%+45.72%-31.85% 771M
Average -0.48%-0.53%-14.33%+21.42% 15.18B
Weighted average by Cap. +0.52%-0.64%-24.64%-5.64%

Financials

2026 *2027 *
Net sales 4.25B 132M 115M 107M 97.96M 185M 12.7B 188M 1.27B 499M 6.21B 495M 484M 21.4B 4.44B 138M 120M 111M 102M 193M 13.27B 197M 1.33B 521M 6.49B 517M 505M 22.36B
Net income 1.14B 35.38M 30.96M 28.63M 26.31M 49.75M 3.41B 50.61M 342M 134M 1.67B 133M 130M 5.75B -
Net Debt - -
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
26-07-20 NT$135.50 +1.12% 232,154
26-07-17 NT$134.00 -3.94% 344,212
26-07-16 NT$139.50 +0.72% 170,758
26-07-15 NT$138.50 0.00% 132,645
26-07-14 NT$138.50 -1.42% 278,284
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
135.50TWD
Average target price
150.00TWD
Spread / Average Target
+10.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3218 Stock